Receptores de estrógeno y progesterona en cáncer de mama: asociación con variables clinicopatológicas

Molina, María L; Reigosa, Aldo; Nobrega, Doris; Molina, Yajaira.
Salus ; 5(3): 34-42, dic. 2001. tab
Artigo em Espanhol | LILACS | ID: lil-502544

Documentos relacionados

  1. Systemic therapy for hormone receptor-positive/human epidermal growth factor receptor 2-negative early stage and metastatic breast cancer.
  2. Efficacy and Safety of CDK4/6 Inhibitors Combined with Endocrine Therapy in HR+/HER-2- ABC Patients: A Systematic Review and Meta-Analysis.
  3. [Clinical observation of palbociclib combined with endocrine therapy in hormone receptor positive and HER2 negative advanced breast cancer].
  4. Progesterone receptors in normal breast development and breast cancer.
  5. Invasive breast cancer: Current perspectives and emerging views.
  6. Breast Cancer Recurrence by Subtype in a Diverse, Contemporary Cohort of Young Women.
  7. Molecular Classification of Breast Cancer.
  8. Atypical cystic hypersecretory lesions of the breast commonly harbour TP53 alterations.
  9. Log odds of positive lymph nodes (LODDS)-based novel nomogram for survival estimation in patients with invasive micropapillary carcinoma of the breast.
  10. [Non-primary solid malignancies of breast in needle core biopsy: a clinicopathological analysis of 23 cases].